Back to search

Recombinant alpha2 interferon-related cardiomyopathy

Data up to Jan 2025

Published1988
Citations79
References15

Total Citations Per Year

Abstract

References (15)

Interferons in the treatment of human cancer.

1984 • 334 citations

Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a Interferon

1984 • 286 citations

Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.

1987 • 165 citations

The alpha interferons: clinical overview.

1987 • 77 citations

A phase I clinical trial of recombinant DNA gamma interferon.

1987 • 46 citations

Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.

1986 • 44 citations

Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.

1985 • 41 citations

Interferon Inhibits Cardiac Cell Function in Vitro

1981 • 38 citations

Deaths Halt Interferon Trials in France

1982 • 34 citations

Reversible arrhythmias observed in patients treated with recombinant alpha2 interferon

1987 • 26 citations

Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.

1983 • 22 citations

Phase-I trial of Ultrapure? human leukocyte interferon in human malignancy

1984 • 22 citations

Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.

1986 • 13 citations

Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.

1986 • 11 citations

Immunological defects precursors of myocarditis and dilated cardiomyopathy?

1985 • 10 citations

Cited By (0)

Loading...
Recombinant alpha2 interferon-related cardiomyopathy (1988) – The American Journal of Medicine | Metascience Observatory Explorer